JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Language

྾

Home
Applications
Targets
Other protein targets
Immune checkpoint proteins
belatacept, Fusion protein of CD80;Fusion protein of CD86, CAS No.rp173527, Fusion protein of CD80;Fusion protein of CD86

belatacept, Fusion protein of CD80;Fusion protein of CD86, CAS No.rp173527, Fusion protein of CD80;Fusion protein of CD86

Features and benefits

Item Number

rp173527

Grouped product items
SKU	Size	Availability	Price	Qty
rp173527-500μg	500μg	Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding.	$1,334.90
rp173527-1mg	1mg	Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding.	$2,334.90

View related series

Basic Description

Product Name	belatacept, Fusion protein of CD80;Fusion protein of CD86, CAS No.rp173527
Grade	Moligand™
Specifications & Purity	Moligand™
Action Type	INHIBITOR
Mechanism of action	Fusion protein of CD80;Fusion protein of CD86

CAS	rp173527

C of A & Other Certificates(BSE/TSE, COO):

Analytical Chart:

1. Latek R, Fleener C, Lamian V, Kulbokas 3rd E, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R. (2009) Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation.. Transplantation, 87 (6): (926-33). [PMID:19300198] [10.1021/op500134e]
2. Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS et al.. (2016) Belatacept and Long-Term Outcomes in Kidney Transplantation.. N Engl J Med, 374 (4): (333-43). [PMID:26816011] [10.1021/op500134e]

Determine the necessary mass, volume, or concentration for preparing a solution.

Determine the dilution needed to prepare a stock solution.